Lv3
350 积分 2023-07-17 加入
The Role of Cemiplimab in Treating Locally Advanced Cutaneous SCC: A UK Single-Centre Experience and the Implications for Surgical Management
11天前
已完结
Surgery versus immunotherapy in locally advanced cutaneous carcinoma of the external ear: A multicenter study
11天前
已完结
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
11天前
已完结
Cemiplimab for recurrent locally advanced cutaneous squamous cell carcinoma
11天前
已完结
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study
11天前
已完结
Real‐World Efficacy and Safety of Anti‐PD‐1 Antibody Therapy for Patients With Advanced Cutaneous Squamous Cell Carcinoma: A Single‐Center Retrospective Study in Japan
11天前
已完结
Antibiotics use decreases survival in cutaneous squamous cell carcinoma patients receiving immune checkpoint inhibitors
11天前
已完结
A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma
11天前
已完结
Real-World Experience With Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
11天前
已完结
Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinoma
11天前
已完结
皖公网安备34019202002308
